DiaMedica Therapeutics Inc.

NASDAQ:DMAC

Biotechnology

Healthcare
$8.38 -0.17%

-$0.01 today

Market cap
$452.16M
Beta
1.00
P/E (TTM)
-8.8
EPS (TTM)
-$0.65
52W Low $3.48High $10.42

Volume 0.29M

Average 0.19M

Price history

DiaMedica Therapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+21.45%

Period high

$10.77

Period low

$5.33

Latest

$8.38

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
4Aug 12, 2026Aug 12, 2026
S-8Aug 11, 2026Aug 11, 2026
10-QAug 10, 2026Aug 10, 2026
8-KAug 10, 2026Aug 10, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026
4Jun 3, 2026Jun 3, 2026

Competitors

Who does DiaMedica Therapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about DMAC's filings, answered from its disclosures.

What is the latest DMAC filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does DMAC have?

Intrinsic Alpha currently shows 20 recent filings for DMAC.